Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
Ua3RkUgqpfxbpZWH
